Hem › Levercancer (hepatocellulärt karcinom) › Tennessee › Nashville
Kliniska studier för Levercancer (hepatocellulärt karcinom) i Nashville, TN
10 studier för Levercancer (hepatocellulärt karcinom) söker deltagare vid platser i och runt Nashville (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Phase 1 Study of the Safety and Tolerability of CTX-10726
RekryterarFas 1
- SCRI Oncology Partners, Nashville
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekryterarFas 1
- Exelixis Clinical Site #3, Nashville
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
RekryterarFas 1/2
- Tennessee Oncology, Nashville
- Vanderbilt University Medical Center, Nashville
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- Scri Oncology Partners, Nashville
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- Sarah Cannon Research Institute, Nashville
- Vanderbilt Ingram Cancer Center, Nashville
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekryterarFas 1/2
- SCRI Oncology Partners, Nashville
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekryterarFas 2
- SCRI - TriStar Medical Group Children's Specialists, Nashville
- SCRI Oncology Partners, Nashville
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
RekryterarFas 1
- HCA Research Institute, LLC, Brentwood · 9 mi bort
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RekryterarFas 1/2
- Research Site 136, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Nashville
Levercancer (hepatocellulärt karcinom)-studier i andra städer
- Houston, TX31 studier
- New York City, NY24 studier
- Dallas, TX19 studier
- Los Angeles, CA19 studier
- Boston, MA18 studier
- Cleveland, OH18 studier
- Chicago, IL16 studier
- Philadelphia, PA16 studier
- Pittsburgh, PA15 studier
- San Francisco, CA14 studier
- Orange, CA14 studier
- Jacksonville, FL14 studier
Andra studier i Nashville
- Icke-småcellig lungcancer97 studier
- Bröstcancer81 studier
- Metastaserande cancer70 studier
- Kolorektal cancer69 studier
- Cancer (alla typer)65 studier
- Äggstockscancer49 studier
- Prostatacancer43 studier
- Lungcancer40 studier
- Plattenepitelcancer i huvud och hals39 studier
- Bukspottkörtelcancer39 studier
- Endometriecancer38 studier
- Melanom33 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.